ClinConnect ClinConnect Logo
Search / Trial NCT06572501

Robot-assisted Laparoscopic Partial Nephrectomy Via the Extraperitoneal Approach in the Prone Position Versus the Lateral Position

Launched by THE FIRST AFFILIATED HOSPITAL WITH NANJING MEDICAL UNIVERSITY · Aug 26, 2024

Trial Information

Current as of July 27, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is investigating a type of surgery called robot-assisted laparoscopic partial nephrectomy, which is used to remove part of a kidney affected by a tumor. The main focus of the study is to compare two different positions during surgery: the prone position (lying face down) and the lateral position (lying on the side). Researchers want to find out if having the surgery in the prone position is safer and better for patients compared to the traditional lateral position, and whether it affects patients' recovery and overall health outcomes.

To participate in this trial, patients need to be at least 18 years old and have imaging results that show a kidney tumor. They also must be eligible for the robotic surgery approach. If enrolled, participants will be randomly assigned to one of the two positions for their surgery and will have follow-up check-ups at various points after surgery to monitor their recovery and health. It's important for potential participants to understand that they will need to provide some personal health information and agree to regular follow-up assessments as part of the study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. . Patients with preoperative imaging suggestive of renal occupancy;
  • 2. . Sex is not limited;
  • 3. . Age ≥18 years;
  • 4. . Clinical staging consistent with indications for partial nephrectomy;
  • 5. . Suitable for robotic-assisted laparoscopic partial nephrectomy via extraperitoneal approach as judged by relevant preoperative clinical data;
  • 6. . Agree to provide basic clinical information and pathological and imaging data for scientific research and sign an informed consent form;
  • 7. . Agree to provide monitoring results during the follow-up recurrence monitoring process.
  • Exclusion Criteria:
  • 1. . Patients who did not meet the indications for partial nephrectomy and did not undergo robotic-assisted laparoscopic partial nephrectomy via extraperitoneal approach;
  • 2. . Patients who refuse to undergo or cannot tolerate surgery in the appropriate position;
  • 3. . Patients with incomplete documentation of relevant data to provide accurate demographic, perioperative, and prognostic data;
  • 4. . Any condition which, in the opinion of the investigator, may be detrimental to the subject or result in the inability of the subject to meet or perform the requirements of the study;
  • 5. . Patients who are unable to provide written informed consent;

About The First Affiliated Hospital With Nanjing Medical University

The First Affiliated Hospital of Nanjing Medical University is a leading medical institution dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital is committed to implementing rigorous scientific methodologies to evaluate new therapies and treatment approaches. With a multidisciplinary team of experienced healthcare professionals and researchers, the hospital fosters a collaborative environment aimed at enhancing patient outcomes and contributing to the global medical community. Its strategic focus on translational medicine ensures that groundbreaking discoveries are efficiently translated into practical applications for patient care.

Locations

Nanjing, Jiangsu, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported